UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection

The Journal of infectious diseases, 2018-05, Vol.217 (11), p.1793-1797

2018

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Standard Follow-Up Completion after Sexual Exposure to HIV: Five-Year Retrospective Analysis in a French HIV-Infection Care Center

PloS one, 2015-12, Vol.10 (12), p.e0145440-e0145440

2015

Link zum Volltext

Verfügbarkeit prüfen

Dolutegravir reshapes the genetic diversity of HIV-1 reservoirs

Journal of antimicrobial chemotherapy, 2018-04, Vol.73 (4), p.1045-1053

2018

Link zum Volltext

Verfügbarkeit prüfen

Distribution and reduction magnitude of HIV-DNA burden in CD4+ T cell subsets depend on art initiation timing

AIDS (London), 2018-04, Vol.32 (7), p.921-926

2018

Link zum Volltext

Verfügbarkeit prüfen

Bone mineral density changes after 2 years of ARV treatment, compared to naive HIV-1-infected patients not on HAART

Infectious diseases (London, England), 2015-02, Vol.47 (2), p.88-95

2015

Link zum Volltext

Verfügbarkeit prüfen

Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy: the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohort

Antiviral therapy, 2015-01, Vol.20 (7), p.763-772

2015

Link zum Volltext

Verfügbarkeit prüfen

Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study

PloS one, 2013-09, Vol.8 (9), p.e74868-e74868

2013

Link zum Volltext

Verfügbarkeit prüfen

Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use

AIDS (London), 2012-01, Vol.26 (2), p.207-215

2012

Link zum Volltext

Verfügbarkeit prüfen

Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partner

PloS one, 2013-07, Vol.8 (7), p.e69144-e69144

2013

Link zum Volltext

Verfügbarkeit prüfen

Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort

Antiviral therapy, 2012, Vol.17 (1), p.91-100

2012

Link zum Volltext

Verfügbarkeit prüfen

Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in antiretroviral-naive HIV-1-infected patients

Journal of acquired immune deficiency syndromes (1999), 2006-12, Vol.43 (5), p.530

2006

Link zum Volltext

Verfügbarkeit prüfen

Tolerance of a short course of nevirapine, associated with 2 nucleoside analogues, in postexposure prophylaxis of HIV

Journal of acquired immune deficiency syndromes (1999), 2004-12, Vol.37 (4), p.1454

2004

Link zum Volltext

Verfügbarkeit prüfen

Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: a median follow-up of 64 weeks

Journal of acquired immune deficiency syndromes (1999), 2001-08, Vol.27 (5), p.459

2001

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of switching to raltegravir plus atazanavir dual therapy in pretreated HIV-1-infected patients over 144 weeks: a cohort study

Scandinavian journal of infectious diseases, 2014-12, Vol.46 (12), p.838-845

2014

Link zum Volltext

Verfügbarkeit prüfen

Fast and Uncooled Semiconducting Ca-Doped Y-Ba-Cu-O Thin Film-Based Thermal Sensors for Infrared

Sensors (Basel, Switzerland), 2023-09, Vol.23 (18), p.7934

2023

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

European journal of cancer (1990), 2020-12, Vol.141, p.62-81

2020

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design

Cell host & microbe, 2019-01, Vol.25 (1), p.59-72.e8

2019

Link zum Volltext

Verfügbarkeit prüfen

Final results from the randomized CABADOC trial: Patient preference between cabazitaxel and docetaxel for first-line chemotherapy in metastatic castrate-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.5017-5017

2019

Link zum Volltext

Verfügbarkeit prüfen

Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients

PloS one, 2015-10, Vol.10 (10), p.e0141164-e0141164

2015

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design

Cell host & microbe, 2019-08, Vol.26 (2), p.296-296

2019

Link zum Volltext

Verfügbarkeit prüfen

Lopinavir/Ritonavir Monotherapy as a Nucleoside Analogue—Sparing Strategy to Prevent HIV-1 Mother-to-Child Transmission: The ANRS 135 PRIMEVA Phase 2/3 Randomized Trial

Clinical infectious diseases, 2013-09, Vol.57 (6), p.891-902

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection

Predictors of Standard Follow-Up Completion after Sexual Exposure to HIV: Five-Year Retrospective Analysis in a French HIV-Infection Care Center

Dolutegravir reshapes the genetic diversity of HIV-1 reservoirs

Distribution and reduction magnitude of HIV-DNA burden in CD4+ T cell subsets depend on art initiation timing

Bone mineral density changes after 2 years of ARV treatment, compared to naive HIV-1-infected patients not on HAART

Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy: the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohort

Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study

Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use

Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partner

Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort

Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in antiretroviral-naive HIV-1-infected patients

Tolerance of a short course of nevirapine, associated with 2 nucleoside analogues, in postexposure prophylaxis of HIV

Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: a median follow-up of 64 weeks

Efficacy and safety of switching to raltegravir plus atazanavir dual therapy in pretreated HIV-1-infected patients over 144 weeks: a cohort study

Fast and Uncooled Semiconducting Ca-Doped Y-Ba-Cu-O Thin Film-Based Thermal Sensors for Infrared

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design

Final results from the randomized CABADOC trial: Patient preference between cabazitaxel and docetaxel for first-line chemotherapy in metastatic castrate-resistant prostate cancer (mCRPC)

Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients

HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design

Lopinavir/Ritonavir Monotherapy as a Nucleoside Analogue—Sparing Strategy to Prevent HIV-1 Mother-to-Child Transmission: The ANRS 135 PRIMEVA Phase 2/3 Randomized Trial

Suchergebnisse filtern